Uterine leiomyomata (fibroids) are the commonest benign pelvic tumours. Therapeutic options include hormone manipulation or surgical management, myomectomy if the patient wishes to retain fertility, or hysterectomy. We describe the use of transcatheter arterial embolisation in a patient who presented with a large uterine fibroid and pressure symptoms. CASE REPORT A forty-two year old female patient presented with acute urinary retention. She was admitted to hospital where a urethral catheter was passed. She described a several month history of occasional difficulty commencing the flow of urine but was otherwise well with no relevant past medical history. Initial assessment included ultrasound, which showed a large uterine fibroid lying at the posterior aspect of the uterus, with a diameter in excess of ten centimetres. Hypervascularity was observed on colour doppler imaging. After discussion of therapeutic alternatives with the patient, we decided on transcatheter percutaneous embolisation of the uterine arteries. Prior to the procedure a prophylactic iv bolus of cefuroxime (750 mg) and metronidazole (400 mg) was given. The Ulster Medical Journal with dilute contrast media and were slowly injected under fluoroscopic guidance until flow in the left uterine artery was abolished.
A 5-French Sos-Omni selective catheter (AngioDynamics, Queensbury, NY) was then used through the arterial sheath to select the ipsilateral right internal iliac artery. A guidewire was placed distally within this artery and an exchange was performed for a Cobra catheter. Again PVA particles were injected slowly with dilute contrast medium, until flow in the right uterine artery was also abolished. In conclusion, percutaneous transcatheter uterine arterial embolisation offers a useful alternative to surgery in the treatment of uterine fibroids. Potential benefits over surgery include reduced post-operative complications, lower costs, shorter hospitalisation and the potential preservation of fertility. Although short-term results have been excellent in our case, and in the two previously described short series6' 7 further work will be necessary with large controlled trials to assess long-term benefit.
